DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Citations Over TimeTop 1% of 2017 papers
Abstract
Radiotherapy is under investigation for its ability to enhance responses to immunotherapy. However, the mechanisms by which radiation induces anti-tumour T cells remain unclear. We show that the DNA exonuclease Trex1 is induced by radiation doses above 12-18 Gy in different cancer cells, and attenuates their immunogenicity by degrading DNA that accumulates in the cytosol upon radiation. Cytosolic DNA stimulates secretion of interferon-β by cancer cells following activation of the DNA sensor cGAS and its downstream effector STING. Repeated irradiation at doses that do not induce Trex1 amplifies interferon-β production, resulting in recruitment and activation of Batf3-dependent dendritic cells. This effect is essential for priming of CD8+ T cells that mediate systemic tumour rejection (abscopal effect) in the context of immune checkpoint blockade. Thus, Trex1 is an upstream regulator of radiation-driven anti-tumour immunity. Trex1 induction may guide the selection of radiation dose and fractionation in patients treated with immunotherapy.
Related Papers
- An overview of scientific and regulatory issues for the immunogenicity of biological products.(2003)
- → Aggregation and Immunogenicity of Therapeutic Proteins(2010)38 cited
- → Immunogenicity of Therapeutic Proteins(2010)29 cited
- [An experimental study of the immunogenicity of Pseudomonas aeruginosa vaccines].(1976)
- → Immunogenicity(2015)